Abstract:Intestinal exocrine secretory cells, including Paneth and goblet cells, have a pivotal role in intestinal barrier function and mucosal immunity. Dysfunction of these cells may lead to the pathogenesis of human diseases such as inflammatory bowel disease (IBD). Therefore, identification and elucidation of key molecular mechanisms that regulate the development and function of these exocrine cells would be crucial for understanding of disease pathogenesis and discovery of new therapeutic targets. The Ufm1 conjugation system is a novel ubiquitin-like modification system that consists of Ufm1 (Ubiquitin modifier 1), Uba5 (Ufm1-activating enzyme, E1), Ufc1 (Ufm1-conjugating enzyme, E2) and poorly characterized Ufm1 E3 ligase(s). Recent mouse genetic studies have demonstrated its indispensable role in embryonic development and hematopoiesis. Yet its role in other tissues and organs remains poorly defined. In this study, we found that both Ufl1 and Ufbp1, two key components of the Ufm1 E3 ligase, were highly expressed in the intestinal exocrine cells. Ablation of either Ufl1 and Ufbp1 led to significant loss of both Paneth and goblet cells, which in turn resulted in dysbiotic microbiota and increased susceptibility to experimentally induced colitis. At the cellular and molecular levels, Ufbp1 deficiency caused elevation of endoplasmic reticulum stress and activation of the Unfolded Protein Response (UPR) and cell death program. Administration of small molecular chaperone partially prevented loss of Paneth cells caused by acute Ufbp1 deletion. Taken together, our results have provided unambiguous evidence for the crucial role of the Ufm1 E3 ligase in maintenance of intestinal homeostasis and protection from inflammatory diseases.

The regulation role of protein ubiquitination in the development and progression of intestinal inflammation

Advance in Research on the Regulation of Innate Immune Response by Ubiquitination

Ubiquitination Regulation of Inflammatory Responses Through NF-κB Pathway.

The Role of E3 Ubiquitin Ligases and Deubiquitinases in Inflammatory Bowel Disease: Friend or Foe?

The role of ubiquitination in health and disease

Ubiquitin-specific Proteases in Inflammatory Bowel Disease-Related Signalling Pathway Regulation

The Role of Ubiquitination in Regulation of Innate Immune Signaling.

Ubiquitination of Immune System and Cancer Therapy

Ubiquitin ligase enzymes and de-ubiquitinating enzymes regulate innate immunity in the TLR, NLR, RLR, and cGAS-STING pathways

Roles of Ubiquitination in the Crosstalk Between Tumors and the Tumor Microenvironment (Review)

Emerging Role of Protein Modification in Inflammatory Bowel Disease.

Ubiquitination Signals Critical to Regulatory T Cell Development and Function

Indispensable Role of the Ubiquitin-fold Modifier 1-Specific E3 Ligase in Maintaining Intestinal Homeostasis and Controlling Gut Inflammation

Regulation of Innate Antiviral Immunity by Protein Ubiquitination

Role of miRNAs in pathogenesis of inflammatory bowel disease

Ubiquitin Signaling in Immune Responses

Posttranslational Modification Control of Inflammatory Signaling

Involvement of the ubiquitin-proteasome system in the regulation of the tumor microenvironment and progression

Small molecules targeting ubiquitination to control inflammatory diseases

Ubiquitination in the regulation of inflammatory cell death and cancer

The role of mesenchymal stem cells in attenuating inflammatory bowel disease through ubiquitination